Geodon for the Treatment of Refractory Social Anxiety Disorder
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness and tolerability of augmentation
treatment of ziprasidone to achieve remission among patients with social anxiety disorder
(SAD) who did not remit on sertraline treatment alone